P
Pramod Guru
Researcher at Mayo Clinic
Publications - 78
Citations - 568
Pramod Guru is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 11, co-authored 57 publications receiving 361 citations. Previous affiliations of Pramod Guru include University of Pittsburgh & Post Graduate Institute of Medical Education and Research.
Papers
More filters
Journal ArticleDOI
Mechanical circulatory assist devices: a primer for critical care and emergency physicians
Ayan Sen,Joel S. Larson,Kianoush Kashani,Stacy Libricz,Bhavesh M. Patel,Pramod Guru,Cory M. Alwardt,Octavio E. Pajaro,J. Christopher Farmer +8 more
TL;DR: To care for patients with mechanical circulatory assist devices, health care providers in emergency departments and intensive care units need to understand the physiology of the devices, the vocabulary of mechanical support, the types of complications patients may have, diagnostic techniques, and decision-making regarding treatment.
Journal ArticleDOI
Extracorporeal Membrane Oxygenation Support in Postcardiotomy Elderly Patients: The Mayo Clinic Experience.
Pankaj Saxena,James R. Neal,Lyle D. Joyce,Kevin L. Greason,Hartzell V. Schaff,Pramod Guru,William Y. Shi,Harold M. Burkhart,Zhuo Li,William C. Oliver,Roxann B. Pike,Dawit T. Haile,Gregory J. Schears +12 more
TL;DR: Postcardiotomy ECMO support in elderly patients is associated with high postoperative morbidity and mortality, Nevertheless, it often provides the last line of therapy for these critically ill patients and may provide positive outcomes in selected subgroups.
Journal ArticleDOI
Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation.
Haya Kaseer,Haya Kaseer,Matthew Soto-Arenall,Devang Sanghavi,John Moss,Robert A. Ratzlaff,Si M. Pham,Pramod Guru +7 more
TL;DR: Extracorporeal membrane oxygenation (ECMO) induces hemostatic alterations that may contribute to hematological complications and bivalirudin is a direct thrombin inhibitor and is inherently not dependent on AT III.
Journal ArticleDOI
Decisions to Withdraw Extracorporeal Membrane Oxygenation Support: Patient Characteristics and Ethical Considerations.
Erin S. DeMartino,Nicholas A. Braus,Daniel P. Sulmasy,J. Kyle Bohman,John M. Stulak,Pramod Guru,Kayla R. Fuechtmann,Nausheen Singh,Gregory J. Schears,Paul S. Mueller +9 more
TL;DR: It is argued that ethically, withdrawal of treatment is sometimes better after the prognosis becomes clear, rather than withholding treatment under conditions of uncertainty, and this rationale provides the best explanation for the behavior observed among clinicians and surrogates of ECMO‐supported patients.
Journal ArticleDOI
The impact of chlorhexidine bathing on hospital-acquired bloodstream infections: a systematic review and meta-analysis.
Jackson S. Musuuza,Pramod Guru,John C. O’Horo,Connie Bongiorno,Marc A. Korobkin,Ronald E. Gangnon,Nasia Safdar +6 more
TL;DR: Patient bathing with CHG significantly reduced the incidence of HABSIs in both ICU and non-ICU settings and fidelity assessment that goes beyond whether a patient received an intervention or not should be standard practice particularly for complex behavioral interventions such as CHG bathing.